Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Avita Medical Inc
(NQ:
RCEL
)
9.340
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Avita Medical Inc
< Previous
1
2
3
Next >
AVITA Medical to Host Investor Webinar Briefing
August 14, 2023
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Reports Second Quarter Financial Results
August 10, 2023
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Inc. (NASDAQ: RCEL) is a Stock Spotlight on 7/25
July 25, 2023
Via
Investor Brand Network
AVITA Medical to Announce Second Quarter 2023 Financial Results
July 20, 2023
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Inc. (NASDAQ: RCEL) is a Stock Spotlight on 7/13
July 13, 2023
Via
Investor Brand Network
AVITA Medical Submits FDA PMA Supplement for RECELL GO
June 29, 2023
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Rejoins the Russell 3000 Index
June 26, 2023
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Announces FDA Approval of RECELL for Skin Repigmentation in Vitiligo Patients
June 16, 2023
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Announces Appointment of David O’Toole as Chief Financial Officer
June 15, 2023
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Inc. (NASDAQ: RCEL) Records 52-Week High Thursday Morning
June 08, 2023
Via
Investor Brand Network
AVITA Medical Announces FDA Approval of RECELL for Treatment of Full-Thickness Skin Defects
June 07, 2023
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical to Host Investor Webinar Briefing
May 15, 2023
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Reports First Quarter Financial Results and Affirms Full Year Guidance
May 11, 2023
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Inc. (NASDAQ: RCEL) is a Stock Spotlight on 5/11
May 11, 2023
Via
Investor Brand Network
AVITA Medical to Announce First Quarter 2023 Financial Results
April 20, 2023
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Announces Update to Automation Device
April 13, 2023
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Appoints New Non-Executive Member to the Board of Directors
March 23, 2023
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Appoints New Non-Executive Member to the Board of Directors
March 16, 2023
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical to Present at the TD Cowen 43rd Annual Health Care Conference
March 02, 2023
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical to Host Investor Webinar Briefing
February 27, 2023
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Guidance
February 23, 2023
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide 2023 Financial Guidance
February 09, 2023
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Announces Management Changes and Fourth Quarter 2022 Earnings Conference Call
January 19, 2023
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Submits FDA PMA Application to Expand Indication to Vitiligo
December 19, 2022
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Announces Results of 2022 Annual Meeting of Stockholders
December 12, 2022
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Submits FDA PMA Supplement to Further Expand Indication to Soft Tissue Repair
December 12, 2022
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical® to Present at the Piper Sandler 34th Annual Healthcare Conference
November 21, 2022
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical® to Host Investor Webinar Briefing
November 16, 2022
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Reports Third Quarter 2022 Financial Results
November 10, 2022
From
AVITA Medical
Via
GlobeNewswire
AVITA Medical Announces Achievement of Co-Primary Endpoints in Updated Analysis of Pivotal Trial of RECELL® System for Soft Tissue Repair
November 09, 2022
From
AVITA Medical
Via
GlobeNewswire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.